1.
Al-Khazragie Z, Sabri M, Sabri L, Al-Atbi H. Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer. Babcock Univ. Med. J. [Internet]. 2026 Sep. 30 [cited 2026 Oct. 25];9(3):151-62. Available from: https://bumj.babcock.edu.ng/index.php/bumj/article/view/1459